E
Catalent, Inc. CTLT
NYSE
Recommendation
Sell
Prev Close
$63.07
Volume
--
Avg Vol (90D)
1,832,223
Market Cap
$11.45B
Dividend & Yield
--
52-Week Range
$40.30 - $63.25
P/E (TTM)
--
EPS (TTM)
-$2.29
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Catalent Announces New Board Appointments
2/20/2025 - Business Wire
LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List
12/20/2024 - Zacks Investment Research
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
12/20/2024 - 24/7 Wall St.
Repligen Corporation (RGEN) Fell Along with Peers
12/20/2024 - Insider Monkey
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
12/19/2024 - 24/7 Wall St.
The volume for CATALENT stock increased for three consecutive days, resulting in a record-breaking daily growth of 412% of the 65-Day Volume Moving Average
12/19/2024 - Tickeron - Stocks
Lennox International Set to Join SandP 500 and BILL Holdings to Join SandP MidCap 400
12/18/2024 - GuruFocus
Lennox International to join SandP 500 before the end of 2024, replacing Catalent
12/18/2024 - SeekingAlpha.com: All News
Lennox International Set to Join SandP 500 and BILL Holdings to Join SandP MidCap 400
12/18/2024 - PR Newswire
Lennox to replace Catalent in SandP 500 at open on 12/23
12/18/2024 - The Fly
Novo Completes $16.5 Billion Acquisition of Catalent
12/18/2024 - GuruFocus
Novo Holdings completes purchase of Catalent
12/18/2024 - SeekingAlpha.com: All News
Novo Holdings completes purchase of Catalent
12/18/2024 - Seeking Alpha - Healthcare
Catalent Acquired by Novo Holdings in $16.5 Billion Deal
12/18/2024 - TipRanks Financial Blog
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
12/18/2024 - 24/7 Wall St.
Novo Holdings Completes Acquisition of Catalent
12/18/2024 - Business Wire
The volume for CATALENT stock increased for two consecutive days, resulting in a record-breaking daily growth of 380% of the 65-Day Volume Moving Average
12/18/2024 - Tickeron - Technical Analysis
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
12/17/2024 - 24/7 Wall St.
NVO to Invest $1.2B in New Rare Disease Drugs Facility in Denmark
12/17/2024 - Zacks Investment Research
The volume for CATALENT stock increased for one day, resulting in a record-breaking daily growth of 238% of the 65-Day Volume Moving Average
12/17/2024 - Tickeron - Stocks
Ally Financial Moves Up In Market Cap Rank, Passing Catalent
12/16/2024 - The Online Investor
Novo Holdings set to close $16.5B Catalent buy in 'coming days' after deal clears antitrust hurdles
12/16/2024 - FiercePharma
Catalent (NYSE:CTLT) Hits New 52-Week High - Should You Buy?
12/16/2024 - MarketBeat
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
12/16/2024 - 24/7 Wall St.
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent
12/16/2024 - Benzinga
Income Statement
Total Revenue (TTM)
$4.42B
EBITDA (TTM)
$462.00M
EBIT (TTM)
-$28.00M
Net Income (TTM)
-$413.00M
Balance Sheet
Total Assets (Q)
$9.71B
Total Debt (Q)
$4.95B
Total Liabilities (Q)
$6.17B
Book Value Per Share (Q)
$19.52
Cash Flow
Cash from Operations (TTM)
$399.00M
Cash from Investing (TTM)
-$277.00M
Cash from Financing (TTM)
-$34.00M
Net Change in Cash (TTM)
$126.00M
Filings
Filing Date
Tuesday, November 5, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Dec 2 and 6 (est)
Price History
Loading...
Beta
1.07
7-Day Total Return
1.12%
30-Day Total Return
7.85%
60-Day Total Return
4.87%
90-Day Total Return
5.68%
Year to Date Total Return
40.00%
1-Year Total Return
50.56%
2-Year Total Return
43.73%
3-Year Total Return
-47.25%
5-Year Total Return
19.00%
52-week Low
Dec 14, 2023 - $40.30
52-week High
Dec 11, 2024 - $63.25
Valuation
Market Cap
$11.45B - Large Cap
Enterprise Value
$16.06B
Price/Sales (TTM)
2.60
Price/Book (Q)
3.23
Dividends and Shares
Shares Outstanding
182.00M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.catalent.com
Phone Number
732 537 6200
Address
14 Schoolhouse Road
Somerset, NJ 08873
Country
United States
Year Founded
1933
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It... more
Weiss Ratings